Sanofi Consumer Healthcare Q1 net profit surges 36% as export sales jump 144% – CNBC TV18
Shares of Sanofi Consumer Healthcare India Ltd ended at ₹4,708.10, up by ₹60.65, or 1.31%, on the BSE.Drug major Sanofi Consumer Healthcare India Ltd on Tuesday (April 28) reported a 35.6% rise in first-quarter net profit at ₹67.8 crore compared with ₹50 crore in the year-ago period. Revenue for the quarter increased 32.8% to ₹229.2 crore from ₹172.6 crore a year earlier.
The company follows the January to December financial year.
EBITDA rose 38.5% to ₹88.8 crore in the March quarter, compared with ₹64.1 crore in the corresponding period last year. EBITDA margin stood at 38.7% versus 37.1% in the same quarter last year.
Also Read: Sanofi Consumer Healthcare declares ₹55 final dividend even as Q4 profit drops 35%, margins shrink
For the quarter ended March 31, 2026, domestic sales grew by 15.5%, aided by the relaunch, and export sales grew by 144.4% on a lower base as compared to the quarter ended March 31, 2025.
Shares of Sanofi Consumer Healthcare India Ltd ended at ₹4,708.10, up by ₹60.65, or 1.31%, on the BSE.
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
